Recabo, Baby Boy .
HRN: 23-45-75 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/22/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/22/2023
09/29/2023
IV
190mg
BID
Prematurity
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes